FindTrial
Sign In

Continuous peripheral block in the pain and ischemic ulcer treatment in arteriopathy patients - ND

Continuous peripheral block in the pain and ischemic ulcer treatment in arteriopathy patients - ND

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-017640-13-IT
Enrollment
Unknown
Registered
2010-09-14
Start date
2010-04-21
Completion date
Unknown
Last updated
2014-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriophaty patients with ischemic pain and/or ulcers MedDRA version: 9.1 Level: SOC Classification code 10047065

Interventions

Trade Name: CHIROCAINE*5F 10ML 5MG/ML PPS Pharmaceutical Form: Solution for injection INN or Proposed INN: Levobupivacaine Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal C

Sponsors

ISTITUTI ORTOPEDICI RIZZOLI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Major; arteriophaty; TcPO2 =65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: under age; pregnant

Design outcomes

Primary

MeasureTime frame
Main Objective: Pain valutation by VAS;Secondary Objective: vascularization improvement; Measurament of ulcer diameter;Primary end point(s): Measurement of pain—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026